Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea in Parkinson’s disease (PD) and other neurological conditions: Results of a Phase III, placebo-controlled, randomized, double-blind study - Jost, W H; Friedman, A; Michel, O (Neurology, 2018)
abs S2.007